Formulation, Evaluation and Optimization of Fast Dissolving Tablets Containing Amlodipine Besylate by Sublimation Method

Authors

  • GY Narmada Department of Pharmaceutics, Visveswarapura Institute of Pharmaceutical Sciences, Bangalore, India
  • K Mohini Department of Pharmaceutics, Visveswarapura Institute of Pharmaceutical Sciences, Bangalore, India
  • B Prakash Rao Department of Pharmaceutics, Visveswarapura Institute of Pharmaceutical Sciences, Bangalore, India
  • DXP Gowrinath Nirmala college of pharmacy,kadapa,India
  • KS Kumar Cherraan’s college of pharmacy,coimbatore, India

Keywords:

Amlodipine besylate, Camphor, Fast dissolving tablets, Sodium starch glycolate, Starch

Abstract

The objective of this research was to formulate fast dissolving tablet of amlodipine besylate for rapid action. Sublimation method was adapted to prepare the tablets by using a 23 full factorial design. FT-IR and D.T.A studies revealed that there was no physico-chemical interaction between amlodipine besylate and other excipients. All formulations are evaluated for pre-compression and post-compression parameters, wetting time, water absorption ratio. The results obtained showed that the quantity of starch potato, sodium starch glycolate, camphor significantly affect response variables. The results indicate that the optimized tablet formulation provides a short DT of 8 sec with sufficient crushing strength and acceptable friability. Stability studies of optimized formulation revealed that formulation is stable.

Downloads

Download data is not yet available.

References

Biradar SS, Bhagavati ST, Kuppasad IJ. Fast dissolving drug delivery systems: a brief overview. The Int. J. Pharmacol 2006;4(2):1531-2976.

Kaushik D, Dureja H, Saini TR. Mouth dissolving tablets: A review.Indian Drugs-Bombay 2004;41:187-93.

Chue P, Welch R, Binder C. Acceptability and disintegration rates of orally disintegrating risperidone tablets in patients with schizophrenia or schizoaffective disorders. Can J Psychiatry 2004;49:701-3.

Shu T, Suzuki H, Hironaka K, Ito K. Studies of rapidly disintegrating tablets in oral cavity using coground mixture of mannitol with crospovidone. Chem Pharm Bull (Tokyo) 2002;50:193-8.

Seager H. Drug delivery products and the zydis fast dissolving dosage form. J Pharm Pharmacol 1998;50:375-8.

Chang RK, Guo X, Burnside BA, Couch RA. Fast dissolving tablets. Pharm Technol 2000;24:52-58.

Shimizu T, Sugaya M, Nakano Y. Formulation study for lansoprazol fast disintegrating tablet, III. Design of rapidly disintegrating tablets. Chem Pharm Bull (Tokyo) 2003;51:1121-27.

Kerins DM, Robertson RM, Robertson D. Chapter 32. Drugs and the drugs used for the treatment of myocardial ischemia. Goodman & Gilman's the Pharmacological Basis of Therapeutics. 10th Ed. JG Hardman, LE Limbird, AG. Gilman, eds. McGraw-Hill, New York, 2001; 843-63.

Available at http://www.rxlist.com/norvasc- drug.html.

Available at http://www.drugs.com/pdr/amlodipine-besylate.html

Masareddy RS, Kadia RV, Manvi FV. Development of mouth dissolving tablets of Clozapine using two different techniques. Indian j pharm sci 2008; 70:526-8.

Sharma S, Gupta GD. Formulation and characterization of fast- dissolving tablet of promethazine theoclate. AJP 2008;2:70-2.

Aryal S, Skalko-basnet N. Stability of Amlodipine besylate and Atenolol in Multi-Component tablets of mono-layer and bi-layer types. Acta pharm 2008;58:299-308.

Ishikawa T, Kuizumi N, Mukai B, Utoguchi N, Fujii M, Matsumoto M, Endo H, Shirrotake S , Watanabe Y. Preparation of rapidly disintegrating tablet using new types of microcrystalline cellulose. Chem.Pharm. Bull 2001;49:134-139.

Adel M, Aley M, Semreen, Mazin K, Qato. To produce rapidly disintegrating Tenoxicam tablet via Camphor sublimation. Pharmaceutical Technology 2005;68-78.

Koizumi K, WatanabeY, Morita K, Utoguchi N, Matsumoto M. New method of preparing high porosity rapid saliva soluble compressed tablet using mannitol with camphor, a subliming material.Int. J. Pharm 1997; 152: 127-131.

Zade PS, Kawtikwar PS, Sakarkar DM. Formulation, Evaluation and optimization of fast dissolving tablet containing Tizanidine hydrochloride.Int j p tech res 2009; 1(1):34-42.

Sarasija S, Pandit V, Joshi HP. Mouth dissolving tablets of Salbutamol sulphate. Indian J Pharm Sci 2007; 69:467-9.

Gohel M, Patel M, Amin A, Agrawal R, Dave R, Bariya N. Formulation design and optimization of mouth dissolve tablets of Nimesulide using vacuum drying technique. AAPS PharmSciTech 2004; 5: article 36.

Shaikh SA, Shaikh SS, Thota RS, Shahi SR, Shookur SA, Pakhare AN. Formulation and development of s-(-)-Amlodipine besylate tablets to improve the dissolution profile. A J P 2007; 1(1): 124-8.

Khan S, Kataria P, Nakhat P, Yeole P. Taste masking of Ondansetron hydrochloride by polymer carrier system and formulation of rapid- disintegrating tablets. AAPS pharmscitech 2007; 8 (2) article 46:e1-7.

Nishii, Hiroyuki, Kobayashi, Hirohisa, Otoda, Kazuya. Tablets Quickly Disintegrated in The Oral Cavity.European Patent EP1153616.

Swamy PV, Areefulla SH, Shirsand SB, Gandra S, Prashanth B. Orodispersible tablets of Meloxicam using disintegrant blends for improved efficacy. Indian j pharm sci 2007; 69:836-40.

Malke S, Shidhaye S, Kadam VJ. Formulation and evaluation of oxicarbazepine fast dissolve tablets. Indian J Pharm Sci 2007;69:211-4.

Available at http:www.pharmainfo.net/reviews/new-generation- tablet-fast-dissolving-tablet. Accessed on Jan 28.2008.

Downloads

Published

2009-09-20

How to Cite

1.
Narmada G, Mohini K, Prakash Rao B, Gowrinath D, Kumar K. Formulation, Evaluation and Optimization of Fast Dissolving Tablets Containing Amlodipine Besylate by Sublimation Method. Ars Pharm [Internet]. 2009 Sep. 20 [cited 2024 Jul. 18];50(3):129-44. Available from: https://revistaseug.ugr.es/index.php/ars/article/view/4895

Issue

Vol. 50 No. 3 (2009)

Section

Original Articles

License

The articles, which are published in this journal, are subject to the following terms in relation to the rights of patrimonial or exploitation:

  1. The authors will keep their copyright and guarantee to the journal the right of first publication of their work, which will be distributed with a Creative Commons BY-NC-SA 4.0 license that allows third parties to reuse the work whenever its author, quote the original source and do not make commercial use of it.

b. The authors may adopt other non-exclusive licensing agreements for the distribution of the published version of the work (e.g., deposit it in an institutional telematic file or publish it in a monographic volume) provided that the original source of its publication is indicated.

c. Authors are allowed and advised to disseminate their work through the Internet (e.g. in institutional repositories or on their website) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).